
Cellectis S.A. CLLS
€ 3.79
-1.34%
Geschäftsbericht 2024
hinzugefügt 03.01.2026
Cellectis S.A. Betriebszyklus 2011-2026 | CLLS
Betriebszyklus Jährlich Cellectis S.A.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 136 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 136 | 136 | 136 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
4.89 | $ 1.06 | -0.93 % | $ 5.78 M | ||
|
Adagene
ADAG
|
53.8 | $ 1.65 | - | $ 92.9 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 64.9 | -0.15 % | $ 8.68 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Biogen
BIIB
|
452 | $ 187.4 | 0.75 % | $ 27.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
BioXcel Therapeutics
BTAI
|
244 | $ 1.98 | -1.0 % | $ 5.02 M | ||
|
CASI Pharmaceuticals
CASI
|
135 | $ 1.04 | -2.34 % | $ 142 M | ||
|
Catalyst Biosciences
CBIO
|
410 | $ 10.74 | -2.1 % | $ 707 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Celldex Therapeutics
CLDX
|
86.5 | $ 27.0 | -1.28 % | $ 1.74 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
195 | $ 27.75 | 0.02 % | $ 1.34 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
408 | $ 11.13 | -2.02 % | $ 720 M | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
Axon Enterprise
AXON
|
116 | $ 633.45 | 3.34 % | $ 48 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
360 | $ 2.64 | -0.75 % | $ 16.6 M | ||
|
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B | ||
|
AstraZeneca PLC
AZN
|
206 | $ 94.65 | 0.68 % | $ 96.9 B | ||
|
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M |